Press Releases

    • November 3, 2021

    Nemaura Medical to Present at the Diabetes Technology Society 2021 Conference on November 4, 2021

    Loughborough, England, Nov. 03, 2021 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on developing...

    Read more
    September 29, 2021

    Nemaura Medical Launches Beta Version of Its Metabolic Health Program

    MiBoKo, a noninvasive glucose sensor utilizing AI mobile application, addresses a substantial multibillion-dollar market opportunity in healthcare LOUGHBOROUGH, England,...

    Read more
    September 27, 2021

    Nemaura Medical Announces Commercial Agreement with UK Licensee

    Nemaura has previously placed order for 200,000 CGMs in anticipation of commercial ramp-up Loughborough, England – September 27, 2021...

    Read more
    September 21, 2021

    Nemaura Medical to Present at the Benzinga Healthcare Small Cap Conference

    Loughborough, England – September 21, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on...

    Read more
    September 17, 2021

    Nemaura Medical announce Professor Osama Hamdy Joins their Advisory Board

    Loughborough, England – September 17, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD)(“Nemaura” or the “Company”), a medical technology...

    Read more
    September 1, 2021

    Nemaura Medical to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference

    Loughborough, England – September 1, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD), a medical technology company focused on...

    Read more
    August 16, 2021

    Nemaura Medical Reports Financial Results and Provides Business Update for the First Fiscal Quarter Ended June 30, 2021

    Loughborough, England – August 16, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (Nasdaq: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    July 12, 2021

    Nemaura Medical to Present at the Access to Giving Virtual Investor Conference on July 13, 2021

    Loughborough, England – July 12, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (Nasdaq: NMRD), a medical technology company focused on...

    Read more
    June 30, 2021

    Nemaura Medical Announces Presentation on its Licensed Why WAIT Program During the American Diabetes Association 81st Annual Scientific Sessions

    Loughborough, England – June 30, 2021 (GlobeNewswire) – Nemaura Medical, Inc. (NASDAQ: NMRD) (“Nemaura” or the “Company”), a medical...

    Read more
    June 30, 2021

    Nemaura Medical Reports Results and Provides Business Update for the Fiscal Year Ended March 31, 2021

    Loughborough, England, June 30, 2021 – Nemaura Medical Inc. (NASDAQ: NMRD) (“Nemaura”), a medical technology company commercializing sugarBEAT®, a...

    Read more